Skip to main content
Have a personal or library account? Click to login
New insight into the effects of lead modulation on antioxidant defense mechanism and trace element concentration in rat bone Cover

New insight into the effects of lead modulation on antioxidant defense mechanism and trace element concentration in rat bone

Open Access
|Jun 2009

References

  1. Agency for Toxic Substances and Disease Registry. (ATSDR, 2005). Draft toxicological profile for lead, pp.102-225, US Department of health and human services, Atlanta, Georgia, USA.
  2. Agency for Toxic Substances and Disease Registry. (ATSDR, 2007). Case studies in Environmental Medicine Lead Toxicity, Course: WB 1105, August 20, Atlanta, Georgia, USA.
  3. Bergmeyer H and Bernt E. (1950).(Varley H, Gowenlock AH, Bell M eds), 5th Edn, pp 741-812 William Heinmann Medical Books Ltd London.
  4. Bird RP and Draper HH. (1980). Effect of malonaldehyde and acetaldehyde on cultured mammalian cells: Growth, morphology, and synthesis of macromolecules.(4): 811-823.
  5. Canalis E, Centrella M, Bunch W and McCarthy TL. (1989). Insulin like growth factor I mediates selective anabolic effects of PTH in bone cultures.: 60-65.
  6. Devasagayam TD and Terachand U. (1987). Decreased lipid peroxidation in rat kidneys during gestation.: 134-138.
  7. Ercal N, Gurer-Orhan H and Aykin-Burns N. (2001). Toxic metals and oxidative stress part I: mechanisms involved in metal-induced oxidative damage. Review.529-539.
  8. Frodovich I. (1995). Superoxide radical and superoxide dismutase.: 97-112.
  9. Habig WH, Pabst MJ and Jackoby WB. (1973). The first enzymatic step in mercapturic formation.: 7130-13 9.
  10. Hande, G and Naran E. (2000). Can antioxidants be beneficial in the treatment of lead poisoning?927-945.
  11. Hayes JD and Pulford DJ. (1995). The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance.: 445-600.
  12. Inouye, Yoshio. (2001). Comparative Study on in vitro Inhibitory Effects of Heavy Metals on Rabbit Drug-Metabolizing Enzymes.: 14-20.
  13. Juberg, DR, Kleiman C F, Kwon, SC. (1997). Position paper of the American council on science and health: Lead and human health., 162-180.
  14. Klein RF and Wiren KM. (1993). Regulation of osteoblastic gene expression by lead.2531-2537.
  15. Kono Y and Fridovich I. (1982). Superoxide radical inhibits catalase.5751-5754.
  16. Kono Y. (1978). Generation of superoxide radical during autooxidation of hydroxylamine and an assay for superoxide dismutase.: 189-195.
  17. Kowaltowski AJ, Vercesi AE, Rhee SG and Netto LE. (2000). Catalases and thioredoxin peroxidase protect Saxxharomyces cerevisiae against Ca2+ induced mitochondrial memebrane permeabilization and cell death.: 177-182.
  18. Liu G, Men P, Kenner GH and Miller SC. (2008). Therapeutic effects of an oral chelator targeting skeletal tissue damage in experimental postmenopausal osteoporosis in rats.181-190.
  19. Lowry OH, Rosebrough NJ, Farr AL and Randall RJ. (1951). Protein measurement with folin phenol reagent.: 265-275.
  20. Luck H. (1971). In: Methods of enzymatic analysis. Ed: H.U. Bergmeyer, Academic Press, New York 885-893.
  21. Lyn P. (2006). Lead toxicity, a review of the literature. Part I: exposure, evaluation and treatment.: 2-22.
  22. Majeska RJ and Wurthier RE. (1975). Studies in matrix vesicles in epiphyseal cartilage I. In vivo incorporation of 32P orthophosphate into phospholipids of chondrocyte, membrane and matrix vesicle fraction.: 51-60.
  23. Mody Nilam, Parhami Farhad A Sarafian Theodore and Linda L Demer. (2001). Oxidative stress modulates osteoblastic differentiation of vascular and bone cells.509-519.
  24. Muller FL, Lustgarten MS, Jang Y, Richardson A, and Van Remmen H. (2007). Trends in oxidative aging theories., 477-503.
  25. Plummer DT. (1988). In: Introduction to practical biochemistry. Third Edition, Copyright ©Tata Mac Graw Hill Company (UK) Limited 220-221.
  26. Pocock NA, Eisman JA, Hopper JL, Yeates MG, Sambrook MG and Ebert TS. (1987). Genetic determinants of bone mass in adults: A twin study.: 706-710.
  27. Pounds JG, Long GJ, and Rosen JF. (1991). Cellular and molecular toxicity of lead in bone.: 17-32.
  28. Sánchez-Rodríguez MA, Ruiz-Ramos M, Correa-Muñoz E and Mendoza-Núñez VM. (2007). Oxidative stress as a risk factor for osteoporosis in elderly Mexicans as characterized by antioxidant enzymes.: 124.
  29. Shen CL, Wang P, Guerrieri J, Yeh JK and Wang JS. (2008). Protective effect of green tea polyphenols on bone loss in middle-aged female rats.979-990.
  30. Shih RA, Hu H, Weisskopf MG and Schwartz BS. (2007). Cumulative lead dose and cognitive function in adults: a review of studies that measured both blood lead and bone lead.483-492.
  31. Shoty K, Weiss DW, Appleby PG, Chebrkin AK, Gloor RFM, Kramens JD. (1998). History of atmosphearic lead deposition since 12,370. (14) C yr BP from a peat bog, jura mountains, Switzerland Science1635 - 1640.
  32. Smith DM Jr, Mielke HW and Heneghan JB. (2008). Subchronic Lead Feeding Study in Male Rats. Arch Environ Contam Toxicol [Epub ahead of print].
  33. Tada-Oikawa S, Oikawa S, Kawanishi M, Yamada M and Kawanishi S. (1999). Generation of hydrogen peroxide precedes loss of mitochondrial memebrane potential during DNA alkylationinduced apoptosis.: 65-69.
  34. Turner RT and Spelsberg TC. (1991). Correlation between mRNA levels for bone cell proteins and bone formation in long bones of maturing rats.: E348-53.
DOI: https://doi.org/10.2478/v10102-009-0003-5 | Journal eISSN: 1337-9569 | Journal ISSN: 1337-6853
Language: English
Page range: 18 - 23
Published on: Jun 19, 2009
Published by: Slovak Academy of Sciences, Institute of Experimental Pharmacology & Toxicology, Centre of Experimental Medicine
In partnership with: Paradigm Publishing Services

© 2009 Bhardwaj Payal, Harkiran Kaur, Durg Rai, published by Slovak Academy of Sciences, Institute of Experimental Pharmacology & Toxicology, Centre of Experimental Medicine
This work is licensed under the Creative Commons License.